Mesa Laboratories, Inc. (MLAB)
- Previous Close
128.55 - Open
127.35 - Bid 129.93 x 100
- Ask 131.74 x 100
- Day's Range
127.35 - 131.87 - 52 Week Range
82.86 - 141.17 - Volume
24,718 - Avg. Volume
31,975 - Market Cap (intraday)
709.06M - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
-- - EPS (TTM)
-46.47 - Earnings Date Nov 4, 2024 - Nov 8, 2024
- Forward Dividend & Yield 0.64 (0.49%)
- Ex-Dividend Date Nov 29, 2024
- 1y Target Est
143.33
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
www.mesalabs.com736
Full Time Employees
March 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: MLAB
View MorePerformance Overview: MLAB
Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MLAB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MLAB
View MoreValuation Measures
Market Cap
695.13M
Enterprise Value
888.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.16
Price/Book (mrq)
4.70
Enterprise Value/Revenue
4.03
Enterprise Value/EBITDA
305.65
Financial Highlights
Profitability and Income Statement
Profit Margin
-111.89%
Return on Assets (ttm)
1.24%
Return on Equity (ttm)
-92.97%
Revenue (ttm)
223.71M
Net Income Avi to Common (ttm)
-250.31M
Diluted EPS (ttm)
-46.47
Balance Sheet and Cash Flow
Total Cash (mrq)
29.99M
Total Debt/Equity (mrq)
146.95%
Levered Free Cash Flow (ttm)
56.69M